Regulation of pentraxin-3 by antioxidants
Hill et al.
Br J Anaesth 2009;0:aep298v1-aep298.
ABSTRACT
| FULL TEXT
Adhesion of Candida albicans to Endothelial Cells under Physiological Conditions of Flow
Grubb et al.
Infect. Immun. 2009;77:3872-3878.
ABSTRACT
| FULL TEXT
Pharmacokinetics and Pharmacodynamics of a Novel Triazole, Isavuconazole: Mathematical Modeling, Importance of Tissue Concentrations, and Impact of Immune Status on Antifungal Effect
Warn et al.
Antimicrob. Agents Chemother. 2009;53:3453-3461.
ABSTRACT
| FULL TEXT
Role for Endosomal and Vacuolar GTPases in Candida albicans Pathogenesis
Johnston et al.
Infect. Immun. 2009;77:2343-2355.
ABSTRACT
| FULL TEXT
Efficacy of a Genetically Engineered Candida albicans tet-NRG1 Strain as an Experimental Live Attenuated Vaccine against Hematogenously Disseminated Candidiasis
Saville et al.
CVI 2009;16:430-432.
ABSTRACT
| FULL TEXT
Trends in Species Distribution and Susceptibility of Bloodstream Isolates of Candida Collected in Monterrey, Mexico, to Seven Antifungal Agents: Results of a 3-Year (2004 to 2007) Surveillance Study
Gonzalez et al.
J. Clin. Microbiol. 2008;46:2902-2905.
ABSTRACT
| FULL TEXT
Empirical Fluconazole versus Placebo for Intensive Care Unit Patients: A Randomized Trial
Schuster et al.
ANN INTERN MED 2008;149:83-90.
ABSTRACT
| FULL TEXT
Use of a Genetically Engineered Strain To Evaluate the Pathogenic Potential of Yeast Cell and Filamentous Forms during Candida albicans Systemic Infection in Immunodeficient Mice
Saville et al.
Infect. Immun. 2008;76:97-102.
ABSTRACT
| FULL TEXT
Management of candidiasis in the intensive care unit
Schelenz
J Antimicrob Chemother 2008;61:i31-i34.
ABSTRACT
| FULL TEXT
Rapid identification of Candida glabrata in Candida bloodstream infections
Foster et al.
J Med Microbiol 2007;56:1639-1643.
ABSTRACT
| FULL TEXT
Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
Parkins et al.
J Antimicrob Chemother 2007;60:613-618.
ABSTRACT
| FULL TEXT
Temporal analysis of Candida albicans gene expression during biofilm development
Yeater et al.
Microbiology 2007;153:2373-2385.
ABSTRACT
| FULL TEXT
Rapid differentiation between fluconazole-sensitive and -resistant species of Candida directly from positive blood-culture bottles by real-time PCR
Metwally et al.
J Med Microbiol 2007;56:964-970.
ABSTRACT
| FULL TEXT
Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts
Spellberg et al.
J. Leukoc. Biol. 2007;81:632-641.
ABSTRACT
| FULL TEXT
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller and Diekema
Clin. Microbiol. Rev. 2007;20:133-163.
ABSTRACT
| FULL TEXT
Effect of Neutropenia and Treatment Delay on the Response to Antifungal Agents in Experimental Disseminated Candidiasis
Hope et al.
Antimicrob. Agents Chemother. 2007;51:285-295.
ABSTRACT
| FULL TEXT
Inhibition of filamentation can be used to treat disseminated candidiasis.
Saville et al.
Antimicrob. Agents Chemother. 2006;50:3312-3316.
ABSTRACT
| FULL TEXT
Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.
Colombo et al.
J. Clin. Microbiol. 2006;44:2816-2823.
ABSTRACT
| FULL TEXT
Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model
Khan and Owais
J Antimicrob Chemother 2006;58:125-132.
ABSTRACT
| FULL TEXT
The Anti-Candida Vaccine Based on the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis.
Ibrahim et al.
Infect. Immun. 2006;74:3039-3041.
ABSTRACT
| FULL TEXT
Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing
Pfaller et al.
Clin. Microbiol. Rev. 2006;19:435-447.
ABSTRACT
| FULL TEXT
Empirical Anti-Candida Therapy among Selected Patients in the Intensive Care Unit: A Cost-Effectiveness Analysis
Golan et al.
ANN INTERN MED 2005;143:857-869.
ABSTRACT
| FULL TEXT
The Anti-Candida albicans Vaccine Composed of the Recombinant N Terminus of Als1p Reduces Fungal Burden and Improves Survival in Both Immunocompetent and Immunocompromised Mice
Spellberg et al.
Infect. Immun. 2005;73:6191-6193.
ABSTRACT
| FULL TEXT
A phagocytic cell line markedly improves survival of infected neutropenic mice
Spellberg et al.
J. Leukoc. Biol. 2005;78:338-344.
ABSTRACT
| FULL TEXT
Frequency of Fungemia in Hospitalized Pediatric Inpatients Over 11 Years at a Tertiary Care Institution
Abelson et al.
Pediatrics 2005;116:61-67.
ABSTRACT
| FULL TEXT
Expression of Genes Encoding Innate Host Defense Molecules in Normal Human Monocytes in Response to Candida albicans
Kim et al.
Infect. Immun. 2005;73:3714-3724.
ABSTRACT
| FULL TEXT
Candida Biofilms: an Update
Ramage et al.
Eukaryot Cell 2005;4:633-638.
FULL TEXT
Retrospective survey of candidaemia in hospitalized patients and molecular investigation of a suspected outbreak
Cliff et al.
J Med Microbiol 2005;54:391-394.
ABSTRACT
| FULL TEXT
Use of Green Fluorescent Protein and Reverse Transcription-PCR To Monitor Candida albicans Agglutinin-Like Sequence Gene Expression in a Murine Model of Disseminated Candidiasis
Green et al.
Infect. Immun. 2005;73:1852-1855.
ABSTRACT
| FULL TEXT
Vaccination with Recombinant N-Terminal Domain of Als1p Improves Survival during Murine Disseminated Candidiasis by Enhancing Cell-Mediated, Not Humoral, Immunity
Ibrahim et al.
Infect. Immun. 2005;73:999-1005.
ABSTRACT
| FULL TEXT
Catheter-Related Bloodstream Infections in the Intensive Care Unit Population
Haase et al.
Journal of Pharmacy Practice 2005;18:42-52.
ABSTRACT
Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model
Andes et al.
Infect. Immun. 2004;72:6023-6031.
ABSTRACT
| FULL TEXT
Impact of Fluconazole Administration on Outcomes in Critically Ill Patients
Garrelts et al.
The Annals of Pharmacotherapy 2004;38:1588-1592.
ABSTRACT
| FULL TEXT
A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999
Lortholary et al.
J Antimicrob Chemother 2004;54:456-464.
ABSTRACT
| FULL TEXT
Rabbit Model of Candida albicans Biofilm Infection: Liposomal Amphotericin B Antifungal Lock Therapy
Schinabeck et al.
Antimicrob. Agents Chemother. 2004;48:1727-1732.
ABSTRACT
| FULL TEXT
Comparison of Mycosis IC/F and Plus Aerobic/F Media for Diagnosis of Fungemia by the Bactec 9240 System
Meyer et al.
J. Clin. Microbiol. 2004;42:773-777.
ABSTRACT
| FULL TEXT
Rapid Identification of Commonly Encountered Candida Species Directly from Blood Culture Bottles
Selvarangan et al.
J. Clin. Microbiol. 2003;41:5660-5664.
ABSTRACT
| FULL TEXT
Parenchymal Organ, and Not Splenic, Immunity Correlates with Host Survival during Disseminated Candidiasis
Spellberg et al.
Infect. Immun. 2003;71:5756-5764.
ABSTRACT
| FULL TEXT
Engineered Control of Cell Morphology In Vivo Reveals Distinct Roles for Yeast and Filamentous Forms of Candida albicans during Infection
Saville et al.
Eukaryot Cell 2003;2:1053-1060.
ABSTRACT
| FULL TEXT
Empirical Therapy for Neonatal Candidemia in Very Low Birth Weight Infants
Benjamin et al.
Pediatrics 2003;112:543-547.
ABSTRACT
| FULL TEXT
Neonatal Candidemia and End-Organ Damage: A Critical Appraisal of the Literature Using Meta-analytic Techniques
Benjamin et al.
Pediatrics 2003;112:634-640.
ABSTRACT
| FULL TEXT
Epidemiology and Outcome of Nosocomial and Community-Onset Bloodstream Infection
Diekema et al.
J. Clin. Microbiol. 2003;41:3655-3660.
ABSTRACT
| FULL TEXT
Sublethal Injury and Resuscitation of Candida albicans after Amphotericin B Treatment
Liao et al.
Antimicrob. Agents Chemother. 2003;47:1200-1206.
ABSTRACT
| FULL TEXT
Use of Amplified Fragment Length Polymorphism Analysis To Identify Medically Important Candida spp., Including C. dubliniensis
Borst et al.
J. Clin. Microbiol. 2003;41:1357-1362.
ABSTRACT
| FULL TEXT
Differential expression of Candida albicans phospholipase B (PLB1) under various environmental and physiological conditions
Mukherjee et al.
Microbiology 2003;149:261-267.
ABSTRACT
| FULL TEXT
Caspofungin Acetate for Treatment of Invasive Fungal Infections
Pacetti and Gelone
The Annals of Pharmacotherapy 2003;37:90-98.
ABSTRACT
| FULL TEXT
Echinocandins -- An Advance in the Primary Treatment of Invasive Candidiasis
Walsh
NEJM 2002;347:2070-2072.
FULL TEXT
Blood Cultures in the Critical Care Unit: Improving Utilization and Yield
Shafazand and Weinacker
Chest 2002;122:1727-1736.
ABSTRACT
| FULL TEXT
Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility
Pfaller and Diekema
J. Clin. Microbiol. 2002;40:3551-3557.
FULL TEXT
Voriconazole and fluconazole susceptibility of Candida isolates
PELLETIER et al.
J Med Microbiol 2002;51:479-483.
ABSTRACT
| FULL TEXT
Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study
Diekema et al.
J. Clin. Microbiol. 2002;40:1298-1302.
ABSTRACT
| FULL TEXT
Management of Candidiasis in Critically Ill Patients
Pai et al.
Journal of Pharmacy Practice 2002;15:106-113.
ABSTRACT
Mixed species biofilms of Candida albicans and Staphylococcus epidermidis
ADAM et al.
J Med Microbiol 2002;51:344-349.
ABSTRACT
| FULL TEXT
Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans
NASH et al.
J Med Microbiol 2002;51:105-109.
ABSTRACT
| FULL TEXT
Candidaemia in patients with dialysis-dependent acute renal failure: aetiology, predisposing and prognostic factors
Sung et al.
Nephrol Dial Transplant 2001;16:2348-2356.
ABSTRACT
| FULL TEXT
Temporal Assessment of Candida Risk Factors in the Surgical Intensive Care Unit
McKinnon et al.
Arch Surg 2001;136:1401-1408.
ABSTRACT
| FULL TEXT
Biofilm Formation by the Fungal Pathogen Candida albicans: Development, Architecture, and Drug Resistance
Chandra et al.
J. Bacteriol. 2001;183:5385-5394.
ABSTRACT
| FULL TEXT
Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo
Mukherjee et al.
Microbiology 2001;147:2585-2597.
ABSTRACT
| FULL TEXT
Complement Is Essential for Protection by an IgM and an IgG3 Monoclonal Antibody Against Experimental, Hematogenously Disseminated Candidiasis
Han et al.
J. Immunol. 2001;167:1550-1557.
ABSTRACT
| FULL TEXT
Prospective Study of Candida Species in Patients at a Comprehensive Cancer Center
Safdar et al.
Antimicrob. Agents Chemother. 2001;45:2129-2133.
ABSTRACT
| FULL TEXT
Novel Fluorescent Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida albicans
Liao et al.
J. Clin. Microbiol. 2001;39:2708-2712.
ABSTRACT
| FULL TEXT
Neutrophil Fc{{gamma}}RI as Target for Immunotherapy of Invasive Candidiasis
van Spriel et al.
J. Immunol. 2001;166:7019-7022.
ABSTRACT
| FULL TEXT
Pharmacodynamics of Amphotericin B in a Neutropenic-Mouse Disseminated-Candidiasis Model
Andes et al.
Antimicrob. Agents Chemother. 2001;45:922-926.
ABSTRACT
| FULL TEXT
Impact of the Order of Initiation of Fluconazole and Amphotericin B in Sequential or Combination Therapy on Killing of Candida albicans In Vitro and in a Rabbit Model of Endocarditis and Pyelonephritis
Louie et al.
Antimicrob. Agents Chemother. 2001;45:485-494.
ABSTRACT
| FULL TEXT
Infections in the Neutropenic Patient-- New Views of an Old Problem
Donowitz et al.
ASH Education Book 2001;2001:113-139.
ABSTRACT
| FULL TEXT
Comparative Genotyping of Candida albicans Bloodstream and Nonbloodstream Isolates at a Polymorphic Microsatellite Locus
Dalle et al.
J. Clin. Microbiol. 2000;38:4554-4559.
ABSTRACT
| FULL TEXT
Evaluation of Outcome of Intravenous Catheter-related Infections in Critically Ill Patients
RELLO et al.
Am. J. Respir. Crit. Care Med. 2000;162:1027-1030.
ABSTRACT
| FULL TEXT
Antifungal Activity of Amphotericin B Cochleates against Candida albicans Infection in a Mouse Model
Zarif et al.
Antimicrob. Agents Chemother. 2000;44:1463-1469.
ABSTRACT
| FULL TEXT
In Vivo Characterization of the Pharmacodynamics of Flucytosine in a Neutropenic Murine Disseminated Candidiasis Model
Andes and van Ogtrop
Antimicrob. Agents Chemother. 2000;44:938-942.
ABSTRACT
| FULL TEXT
Evaluation of a Capacitance Method for Direct Antifungal Susceptibility Testing of Yeasts in Positive Blood Cultures
Chang Chang et al.
J. Clin. Microbiol. 2000;38:971-976.
ABSTRACT
| FULL TEXT
Mechanisms of the Proinflammatory Response of Endothelial Cells to Candida albicans Infection
Orozco et al.
Infect. Immun. 2000;68:1134-1141.
ABSTRACT
| FULL TEXT
Preliminary Evaluation of a Semisolid Agar Antifungal Susceptibility Test for Yeasts and Molds
Provine and Hadley
J. Clin. Microbiol. 2000;38:537-541.
ABSTRACT
| FULL TEXT
Interaction between Fluconazole and Amphotericin B in Mice with Systemic Infection Due to Fluconazole-Susceptible or -Resistant Strains of Candida albicans
Louie et al.
Antimicrob. Agents Chemother. 1999;43:2841-2847.
ABSTRACT
| FULL TEXT
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
Ghannoum and Rice
Clin. Microbiol. Rev. 1999;12:501-517.
ABSTRACT
| FULL TEXT
A New Azole Derivative of 1,4-Benzothiazine Increases the Antifungal Mechanisms of Natural Effector Cells
Pitzurra et al.
Antimicrob. Agents Chemother. 1999;43:2170-2175.
ABSTRACT
| FULL TEXT
The Attributable Mortality and Costs of Primary Nosocomial Bloodstream Infections in the Intensive Care Unit
DIGIOVINE et al.
Am. J. Respir. Crit. Care Med. 1999;160:976-981.
ABSTRACT
| FULL TEXT
Candida Infections in Critically Ill Trauma Patients: A Retrospective Case-Control Study
Borzotta and Beardsley
Arch Surg 1999;134:657-665.
ABSTRACT
| FULL TEXT
Production, Characterization, and Epitope Mapping of a Monoclonal Antibody against Aspartic Proteinase of Candida albicans
Na et al.
CVI 1999;6:429-433.
ABSTRACT
| FULL TEXT
Serum Is More Suitable than Whole Blood for Diagnosis of Systemic Candidiasis by Nested PCR
Bougnoux et al.
J. Clin. Microbiol. 1999;37:925-930.
ABSTRACT
| FULL TEXT
Trends in Antifungal Use and Epidemiology of Nosocomial Yeast Infections in a University Hospital
Berrouane et al.
J. Clin. Microbiol. 1999;37:531-537.
ABSTRACT
| FULL TEXT
Pharmacodynamics of Fluconazole in a Murine Model of Systemic Candidiasis
Louie et al.
Antimicrob. Agents Chemother. 1998;42:1105-1109.
ABSTRACT
| FULL TEXT
Fluconazole Pharmacokinetics in Burn Patients
Boucher et al.
Antimicrob. Agents Chemother. 1998;42:930-933.
ABSTRACT
| FULL TEXT
Rapid Detection of Candida albicans in Clinical Samples by DNA Amplification of Common Regions from C. albicans-Secreted Aspartic Proteinase Genes
Flahaut et al.
J. Clin. Microbiol. 1998;36:395-401.
ABSTRACT
| FULL TEXT
Impact of Methicillin Resistance on the Outcome of Patients With Bacteremia Caused by Staphylococcus aureus
Harbarth et al.
Arch Intern Med 1998;158:182-189.
ABSTRACT
| FULL TEXT
The Effect of Empiric and Prophylactic Treatment With Fluconazole on Yeast Isolates in a Surgical Trauma Intensive Care Unit
Safran and Dawson
Arch Surg 1997;132:1184-1189.
ABSTRACT
Single-Organism Model of Host Defense against Infection: A Novel Immunotoxicologic Approach to Evaluate Immunomodulatory Drugs
Herzyk et al.
Toxicol Pathol 1997;25:351-362.
ABSTRACT
Emerging and Reemerging Microbial Threats: Nosocomial Fungal Infections
Henderson and Hirvela
Arch Surg 1996;131:330-337.
ABSTRACT
Therapeutic Approaches in Patients With Candidemia: Evaluation in a Multicenter, Prospective, Observational Study
Nguyen et al.
Arch Intern Med 1995;155:2429-2435.
ABSTRACT
The Treatment of Candidemia
DiNubile et al.
NEJM 1995;332:1100-1102.
FULL TEXT
How Bad Are Bacteremia and Sepsis? Outcomes in a Cohort With Suspected Bacteremia
Bates et al.
Arch Intern Med 1995;155:593-598.
ABSTRACT
A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia
Rex et al.
NEJM 1994;331:1325-1330.
ABSTRACT
| FULL TEXT
Management of Candidemia
Meunier
NEJM 1994;331:1371-1372.
FULL TEXT
Mortality of Hospitalized Patients With Candida Endophthalmitis
Menezes et al.
Arch Intern Med 1994;154:2093-2097.
ABSTRACT
Nosocomial Bloodstream Infection in Critically III Patients: Excess Length of Stay, Extra Costs, and Attributable Mortality
Pittet et al.
JAMA 1994;271:1598-1601.
ABSTRACT
Oral Azole Drugs as Systemic Antifungal Therapy
Como and Dismukes
NEJM 1994;330:263-272.
FULL TEXT
Defining Risks for Nosocomial Candidemia
HENDERSON
Arch Intern Med 1989;149:2172-2173.
ABSTRACT
Risk Factors for Hospital-Acquired Candidemia: A Matched Case-Control Study
Wey et al.
Arch Intern Med 1989;149:2349-2353.
ABSTRACT
